跳至主要内容
临床试验/NCT00786253
NCT00786253已完成2 期

A Randomized, Explorative, Double-blind, Double-dummy, Multi-center, Parallel Group Study to Assess Sustainable Efficacy of Once Daily Vardenafil (10 mg) for 12 and 24 Weeks Versus Vardenafil PRN in Men With Mild or Mild to Moderate ED

Bayer0 个研究点目标入组 236 人开始时间: 2005年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Bayer
入组人数
236
主要终点
Erectile Dysfunction change score from baseline of the ED change score from baseline of the International Index of Erectile Function (IIEF-EF)

研究概览

简要总结

Compare once daily vs on demand treatment in men with erectile dysfunction.

Treatment of mild to moderate erectile dysfunction with 10 mg vardenafil p.o. over 24 weeks + 4 weeks wash-out:

A: once daily at bedtime for 12 weeks followed by 12 weeks of placebo B: once daily at bedtime for 24 weeksC: PRN for 24 weeks

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Males 18-64 years of age
  • Mild or mild to moderate ED (defined as >15 and <21 score points according to the Erectile Function Domain Score from IIEF as assessed at the randomisation visit)
  • History of at least one of the following conditions: Diabetes mellitus type 2, hypertension, peripheral arterial occlusive disease
  • Stable, heterosexual relationship for more than six months

排除标准

  • Primary hypoactive sexual desire
  • History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
  • Nitrate therapy.

研究组 & 干预措施

Arm 1

Experimental

干预措施: Levitra (Vardenafil, BAY38-9456) (Drug)

Arm 2

Experimental

干预措施: Levitra (Vardenafil, BAY38-9456) (Drug)

结局指标

主要结局

Erectile Dysfunction change score from baseline of the ED change score from baseline of the International Index of Erectile Function (IIEF-EF)

时间窗: 12- 24 weeks

次要结局

  • SEP 3(12- 24 weeks)
  • SEP 2(12- 24 weeks)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验

Sustainable Efficacy of Vardenafil OD Versus... | 临床试验